RANKL expression could eventually be very dependent on the tumor microenvironment, where adjacent cells like cancer-associated fibroblasts are able to influence RANKL presence to the disadvantage of OPG expression, which could favor bone resorption [53]. This evidence concerns the gene TNFRSF11B and cancer.